Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Andrade

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Journal of Cardiovascular Electrophysiology|December 2, 2021
Bayesian network meta-analysis comparing cryoablation, radiofrequency ablation, and antiarrhythmic drugs as initial therapies for atrial fibrillationMahmoud Elsayed, Omar M Abdelfattah, Ahmed Sayed, et al.
The Canadian Journal of Cardiology|May 11, 2023
Canadian Cardiovascular Society-Canadian Heart Failure Society Focused Clinical Practice Update of Patients With Differing Heart Failure PhenotypesAnique Ducharme, Shelley Zieroth, Vineeta Ahooja, et al.
BMC Cardiovascular Disorders|July 16, 2024
A danish healthcare-focused economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillationMorten Lock Hansen, Joe W E Moss, Jacob Tønnesen, et al.
Journal of Cardiovascular Electrophysiology|March 3, 2015
Blood Pressure and Atrial Fibrillation: A Combined AF-CHF and AFFIRM AnalysisMaxime Tremblay-Gravel, Michel White, Denis Roy, et al.
Circulation|February 8, 2013
Cardiac resynchronization therapy in patients with heart failure and a QRS complex <120 milliseconds: the Evaluation of Resynchronization Therapy for Heart Failure (LESSER-EARTH) trialBernard Thibault, François Harel, Anique Ducharme, et al.
European Journal of Heart Failure|October 10, 2014
Systolic blood pressure and mortality in patients with atrial fibrillation and heart failure: insights from the AFFIRM and AF-CHF studiesMaxime Tremblay-Gravel, Paul Khairy, Denis Roy, et al.
Heart Rhythm|October 25, 2021
Predictors of perforation during lead extraction: Results of the Canadian Lead ExtrAction Risk (CLEAR) studyJamil Bashir, Arthur J Lee, Francois Philippon, et al.
The Canadian Journal of Cardiology|July 6, 2016
Predictors of Ventricular Arrhythmias and Sudden Death in a Québec Cohort With Brugada SyndromeLena Rivard, Antoine Roux, Isabelle Nault, et al.
Heart Rhythm|May 21, 2023
Influence of monitoring and atrial arrhythmia burden on quality of life and health care utilization in patients undergoing pulsed field ablation: A secondary analysis of the PULSED AF trialAtul Verma, David E Haines, Lucas V Boersma, et al.
American Heart Journal|August 28, 2022
Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationalePablo B Nery, George A Wells, Atul Verma, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Journal of Cardiovascular Electrophysiology|December 2, 2021
Bayesian network meta-analysis comparing cryoablation, radiofrequency ablation, and antiarrhythmic drugs as initial therapies for atrial fibrillationMahmoud Elsayed, Omar M Abdelfattah, Ahmed Sayed, et al.
The Canadian Journal of Cardiology|May 11, 2023
Canadian Cardiovascular Society-Canadian Heart Failure Society Focused Clinical Practice Update of Patients With Differing Heart Failure PhenotypesAnique Ducharme, Shelley Zieroth, Vineeta Ahooja, et al.
BMC Cardiovascular Disorders|July 16, 2024
A danish healthcare-focused economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillationMorten Lock Hansen, Joe W E Moss, Jacob Tønnesen, et al.
Journal of Cardiovascular Electrophysiology|March 3, 2015
Blood Pressure and Atrial Fibrillation: A Combined AF-CHF and AFFIRM AnalysisMaxime Tremblay-Gravel, Michel White, Denis Roy, et al.
Circulation|February 8, 2013
Cardiac resynchronization therapy in patients with heart failure and a QRS complex <120 milliseconds: the Evaluation of Resynchronization Therapy for Heart Failure (LESSER-EARTH) trialBernard Thibault, François Harel, Anique Ducharme, et al.
European Journal of Heart Failure|October 10, 2014
Systolic blood pressure and mortality in patients with atrial fibrillation and heart failure: insights from the AFFIRM and AF-CHF studiesMaxime Tremblay-Gravel, Paul Khairy, Denis Roy, et al.
Heart Rhythm|October 25, 2021
Predictors of perforation during lead extraction: Results of the Canadian Lead ExtrAction Risk (CLEAR) studyJamil Bashir, Arthur J Lee, Francois Philippon, et al.
The Canadian Journal of Cardiology|July 6, 2016
Predictors of Ventricular Arrhythmias and Sudden Death in a Québec Cohort With Brugada SyndromeLena Rivard, Antoine Roux, Isabelle Nault, et al.
Heart Rhythm|May 21, 2023
Influence of monitoring and atrial arrhythmia burden on quality of life and health care utilization in patients undergoing pulsed field ablation: A secondary analysis of the PULSED AF trialAtul Verma, David E Haines, Lucas V Boersma, et al.
American Heart Journal|August 28, 2022
Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationalePablo B Nery, George A Wells, Atul Verma, et al.
Pageof 6